-
1
-
-
5444262511
-
Toll-like receptor control of the adaptive immune responses
-
15454922
-
A.Iwasaki, R.Medzhitov. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004; 5:987-95; PMID:15454922; http://dx.doi.org/10.1038/ni1112
-
(2004)
Nat Immunol
, vol.5
, pp. 987-995
-
-
Iwasaki, A.1
Medzhitov, R.2
-
2
-
-
61849170035
-
TLRs and innate immunity
-
18757776
-
B.A.Beutler. TLRs and innate immunity. Blood 2009; 113:1399-407; PMID:18757776; http://dx.doi.org/10.1182/blood-2008-07-019307
-
(2009)
Blood
, vol.113
, pp. 1399-1407
-
-
Beutler, B.A.1
-
3
-
-
0037726802
-
OM-174, a new adjuvant with a potential for human use, induces a protective response when administered with the synthetic C-terminal fragment 242-310 from the circumsporozoite protein of Plasmodium berghei
-
12744882
-
V.Meraldi, R.Audran, J.F.Romero, V.Brossard, J.Bauer, J.A.Lopez, G.Corradin. OM-174, a new adjuvant with a potential for human use, induces a protective response when administered with the synthetic C-terminal fragment 242-310 from the circumsporozoite protein of Plasmodium berghei. Vaccine 2003; 21:2485-91; PMID:12744882; http://dx.doi.org/10.1016/S0264-410X(03)00093-8
-
(2003)
Vaccine
, vol.21
, pp. 2485-2491
-
-
Meraldi, V.1
Audran, R.2
Romero, J.F.3
Brossard, V.4
Bauer, J.5
Lopez, J.A.6
Corradin, G.7
-
4
-
-
2342473348
-
Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies
-
15097956
-
J.Geisse, I.Caro, J.Lindholm, L.Golitz, P.Stampone, M.Owens. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies. J Am Acad Dermatol 2004; 50:722-33; PMID:15097956; http://dx.doi.org/10.1016/j.jaad.2003.11.066
-
(2004)
J Am Acad Dermatol
, vol.50
, pp. 722-733
-
-
Geisse, J.1
Caro, I.2
Lindholm, J.3
Golitz, L.4
Stampone, P.5
Owens, M.6
-
5
-
-
77957680668
-
The TLR7 agonists imiquimod and gardiquimod improve DC-based immunotherapy for melanoma in mice
-
20543857
-
F.Ma, J.Zhang, J.Zhang, C.Zhang. The TLR7 agonists imiquimod and gardiquimod improve DC-based immunotherapy for melanoma in mice. Cell Mol Immunol 2010; 7:381-8; PMID:20543857; http://dx.doi.org/10.1038/cmi.2010.30
-
(2010)
Cell Mol Immunol
, vol.7
, pp. 381-388
-
-
Ma, F.1
Zhang, J.2
Zhang, J.3
Zhang, C.4
-
6
-
-
70350664389
-
Cancer cells expressing toll-like receptors and the tumor microenvironment
-
19685283
-
Y.Sato, Y.Goto, N.Narita, D.S.Hoon. Cancer cells expressing toll-like receptors and the tumor microenvironment. Cancer Microenvir 2009; 2 Suppl 1:205-14; PMID: 19685283; http://dx.doi.org/10.1007/s12307-009-0022-y
-
(2009)
Cancer Microenvir
, vol.2
, pp. 205-214
-
-
Sato, Y.1
Goto, Y.2
Narita, N.3
Hoon, D.S.4
-
7
-
-
66149140644
-
Triggering of Toll-like receptor 4 expressed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attack
-
19318560
-
M.J.Szczepanski, M.Czystowska, M.Szajnik, M.Harasymczuk, M.Boyiadzis, A.Kruk-Zagajewska, W.Szyfter, J.Zeromski, T.L.Whiteside. Triggering of Toll-like receptor 4 expressed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attack. Cancer Res 2009; 69:3105-13; PMID:19318560; http://dx.doi.org/10.1158/0008-5472.CAN-08-3838.
-
(2009)
Cancer Res
, vol.69
, pp. 3105-3113
-
-
Szczepanski, M.J.1
Czystowska, M.2
Szajnik, M.3
Harasymczuk, M.4
Boyiadzis, M.5
Kruk-Zagajewska, A.6
Szyfter, W.7
Zeromski, J.8
Whiteside, T.L.9
-
8
-
-
34248175039
-
Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro
-
17373717
-
J.M.Ilvesaro, M.A.Merrell, T.M.Swain, J.Davidson, M.Zayzafoon, K.W.Harris, K.S.Selander. Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro. The Prostate 2007; 67:774-81; PMID:17373717; http://dx.doi.org/10.1002/pros.20562
-
(2007)
The Prostate
, vol.67
, pp. 774-781
-
-
Ilvesaro, J.M.1
Merrell, M.A.2
Swain, T.M.3
Davidson, J.4
Zayzafoon, M.5
Harris, K.W.6
Selander, K.S.7
-
9
-
-
35848956325
-
Increased toll-like receptor 9 expression in cervical neoplasia
-
17440926
-
J.W.Lee, J.J.Choi, E.S.Seo, M.J.Kim, W.Y.Kim, C.H.Choi, T.J.Kim, B.G.Kim, S.Y.Song, D.S.Bae. Increased toll-like receptor 9 expression in cervical neoplasia. Mol Carcinogen 2007; 46:941-7; PMID:17440926; http://dx.doi.org/10.1002/mc.20325
-
(2007)
Mol Carcinogen
, vol.46
, pp. 941-947
-
-
Lee, J.W.1
Choi, J.J.2
Seo, E.S.3
Kim, M.J.4
Kim, W.Y.5
Choi, C.H.6
Kim, T.J.7
Kim, B.G.8
Song, S.Y.9
Bae, D.S.10
-
10
-
-
40549144396
-
Increased expression of Toll-like receptor 5 during progression of cervical neoplasia
-
17587322
-
W.Y.Kim, J.W.Lee, J.J.Choi, C.H.Choi, T.J.Kim, B.G.Kim, S.Y.Song, D.S.Bae. Increased expression of Toll-like receptor 5 during progression of cervical neoplasia. Int J Gynecol Cancer 2008; 18:300-5; PMID:17587322; http://dx.doi.org/10.1111/j.1525-1438.2007.01008.x
-
(2008)
Int J Gynecol Cancer
, vol.18
, pp. 300-305
-
-
Kim, W.Y.1
Lee, J.W.2
Choi, J.J.3
Choi, C.H.4
Kim, T.J.5
Kim, B.G.6
Song, S.Y.7
Bae, D.S.8
-
11
-
-
33645755382
-
TLR3 can directly trigger apoptosis in human cancer cells
-
B.Salaun, I.Coste, M.C.Rissoan, S.J.Lebecque, T.Renno. TLR3 can directly trigger apoptosis in human cancer cells. J Immunol 2006; 176:4894-901; PMID:16585585; http://dx.doi.org/10.4049/jimmunol.176.8.4894
-
(2006)
J Immunol
, vol.176
, pp. 4894-4901
-
-
Salaun, B.1
Coste, I.2
Rissoan, M.C.3
Lebecque, S.J.4
Renno, T.5
-
12
-
-
84896495897
-
Phosphorothioate-modified CpG oligodeoxynucleotide (CpG ODN) induces apoptosis of human hepatocellular carcinoma cells independent of TLR9
-
24452201
-
Y.Y.Zhang, A.Lin, C.Zhang, Z.G.Tian, J.Zhang. Phosphorothioate-modified CpG oligodeoxynucleotide (CpG ODN) induces apoptosis of human hepatocellular carcinoma cells independent of TLR9. Cancer Immunol Immun 2014; 63:357-67; PMID:24452201; http://dx.doi.org/10.1007/s00262-014-1518-y
-
(2014)
Cancer Immunol Immun
, vol.63
, pp. 357-367
-
-
Zhang, Y.Y.1
Lin, A.2
Zhang, C.3
Tian, Z.G.4
Zhang, J.5
-
13
-
-
33747830764
-
Hepatocellular carcinoma pathogenesis: from genes to environment
-
16929323
-
P.A.Farazi, R.A.DePinho. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 2006; 6:674-87; PMID:16929323; http://dx.doi.org/doi:10.1038/nrc1934
-
(2006)
Nat Rev Cancer
, vol.6
, pp. 674-687
-
-
Farazi, P.A.1
DePinho, R.A.2
-
14
-
-
7044272630
-
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
-
15508101
-
G.Fattovich, T.Stroffolini, I.Zagni, F.Donato. Hepatocellular carcinoma in cirrhosis: Incidence and risk factors. Gastroenterology 2004; 127:S35-S50; PMID:15508101; http://dx.doi.org/10.1053/j.gastro.2004.09.014
-
(2004)
Gastroenterology
, vol.127
, pp. S35-S50
-
-
Fattovich, G.1
Stroffolini, T.2
Zagni, I.3
Donato, F.4
-
15
-
-
33645734597
-
Gut flora and bacterial translocation in chronic liver disease
-
16570339
-
J.Almeida, S.Galhenage, J.Yu, J.Kurtovic, S.M.Riordan. Gut flora and bacterial translocation in chronic liver disease. World J Gastroenterol 2006; 12:1493-502; PMID:16570339; http://dx.doi.org/10.3748/wjg.v12.i10.1493
-
(2006)
World J Gastroenterol
, vol.12
, pp. 1493-1502
-
-
Almeida, J.1
Galhenage, S.2
Yu, J.3
Kurtovic, J.4
Riordan, S.M.5
-
16
-
-
66349110620
-
Toll-like receptors as targets in chronic liver diseases
-
19359436
-
A.Mencin, J.Kluwe, R.F.Schwabe. Toll-like receptors as targets in chronic liver diseases. Gut 2009; 58:704-20; PMID:19359436; http://dx.doi.org/10.1136/gut.2008.156307
-
(2009)
Gut
, vol.58
, pp. 704-720
-
-
Mencin, A.1
Kluwe, J.2
Schwabe, R.F.3
-
17
-
-
84859812538
-
Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
-
D.H.Dapito, A.Mencin, G.Y.Gwak, J.P.Pradere, M.K.Jang, I.Mederacke, J.M.Caviglia, H.Khiabanian, A.Adeyemi, R.Bataller et al. Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4. Cancer Cell 2012; 21:504-16; PMID:22516259; http://dx.doi.org/10.1016/j.ccr.2012.02.007
-
(2012)
Cancer Cell
, vol.21
, pp. 504-516
-
-
Dapito, D.H.1
Mencin, A.2
Gwak, G.Y.3
Pradere, J.P.4
Jang, M.K.5
Mederacke, I.6
Caviglia, J.M.7
Khiabanian, H.8
Adeyemi, A.9
Bataller, R.10
-
18
-
-
0035902115
-
Proliferation, cell cycle and apoptosis in cancer
-
11357141
-
G.I.Evan, K.H.Vousden. Proliferation, cell cycle and apoptosis in cancer. Nature 2001; 411:342-8; PMID:11357141; http://dx.doi.org/10.1038/35077213
-
(2001)
Nature
, vol.411
, pp. 342-348
-
-
Evan, G.I.1
Vousden, K.H.2
-
19
-
-
79751492851
-
NF-kappa B in the liver-linking injury, fibrosis and hepatocellular carcinoma
-
21293511
-
T.Luedde, R.F.Schwabe. NF-kappa B in the liver-linking injury, fibrosis and hepatocellular carcinoma. Nat Rev Gastro Hepat 2011; 8:108-18; PMID:21293511; http://dx.doi.org/10.1038/nrgastro.2010.213
-
(2011)
Nat Rev Gastro Hepat
, vol.8
, pp. 108-118
-
-
Luedde, T.1
Schwabe, R.F.2
-
20
-
-
34249707214
-
Nuclear factor-kappaB: activation and regulation during toll-like receptor signaling
-
17349209
-
R.J.Carmody, Y.H.Chen. Nuclear factor-kappaB: activation and regulation during toll-like receptor signaling. Cell Mol Immunol 2007; 4:31-41; PMID:17349209
-
(2007)
Cell Mol Immunol
, vol.4
, pp. 31-41
-
-
Carmody, R.J.1
Chen, Y.H.2
-
21
-
-
40649087829
-
Growth inhibition of human hepatocellular carcinoma cells by blocking STAT3 activation with decoy-ODN
-
18248786
-
X.Sun, J.Zhang, L.Wang, Z.Tian. Growth inhibition of human hepatocellular carcinoma cells by blocking STAT3 activation with decoy-ODN. Cancer Lett 2008; 262:201-13; PMID:18248786; http://dx.doi.org/10.1016/j.canlet.2007.12.009
-
(2008)
Cancer Lett
, vol.262
, pp. 201-213
-
-
Sun, X.1
Zhang, J.2
Wang, L.3
Tian, Z.4
-
22
-
-
70350500225
-
STATs in cancer inflammation and immunity: a leading role for STAT3
-
19851315
-
H.Yu, D.Pardoll, R.Jove. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 2009; 9:798-809; PMID:19851315; http://dx.doi.org/10.1038/nrc2734
-
(2009)
Nat Rev Cancer
, vol.9
, pp. 798-809
-
-
Yu, H.1
Pardoll, D.2
Jove, R.3
-
23
-
-
78650859531
-
NF-kappaB and STAT3 - key players in liver inflammation and cancer
-
G.He, M.Karin. NF-kappaB and STAT3 - key players in liver inflammation and cancer. Cell Res 2011; 21:159-68; PMID:21187858; http://dx.doi.org/10.1038/cr.2010.183.
-
(2011)
Cell Res
, vol.21
, pp. 159-168
-
-
He, G.1
Karin, M.2
-
24
-
-
0033590207
-
The role of cyclooxygenases in inflammation, cancer, and development
-
C.S.Williams, M.Mann, R.N.DuBois. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 1999; 18:7908-16; PMID:10630643
-
(1999)
Oncogene
, vol.18
, pp. 7908-7916
-
-
Williams, C.S.1
Mann, M.2
DuBois, R.N.3
-
25
-
-
0034905269
-
Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398
-
11350912
-
S.H.Bae, E.S.Jung, Y.M.Park, B.S.Kim, B.K.Kim, D.G.Kim, W.S.Ryu. Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398. Clin Cancer Res 2001; 7:1410-8; PMID:11350912
-
(2001)
Clin Cancer Res
, vol.7
, pp. 1410-1418
-
-
Bae, S.H.1
Jung, E.S.2
Park, Y.M.3
Kim, B.S.4
Kim, B.K.5
Kim, D.G.6
Ryu, W.S.7
-
26
-
-
12444342437
-
Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma
-
M.Soresi, C.Magliarisi, P.Campagna, G.Leto, G.Bonfissuto, A.Riili, A.Carroccio, R.Sesti, S.Tripi, G.Montalto. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma. Anticancer Res 2003; 23:1747-53; PMID:12820452
-
(2003)
Anticancer Res
, vol.23
, pp. 1747-1753
-
-
Soresi, M.1
Magliarisi, C.2
Campagna, P.3
Leto, G.4
Bonfissuto, G.5
Riili, A.6
Carroccio, A.7
Sesti, R.8
Tripi, S.9
Montalto, G.10
-
27
-
-
0033509708
-
Serum vascular endothelial growth factor is a predictor of invasion and metastasis in hepatocellular carcinoma
-
10746978
-
X.M.Li, Z.Y.Tang, L.X.Qin, J.Zhou, H.C.Sun. Serum vascular endothelial growth factor is a predictor of invasion and metastasis in hepatocellular carcinoma. J Exp Clin Canc Res 1999; 18:511-7; PMID:10746978
-
(1999)
J Exp Clin Canc Res
, vol.18
, pp. 511-517
-
-
Li, X.M.1
Tang, Z.Y.2
Qin, L.X.3
Zhou, J.4
Sun, H.C.5
-
28
-
-
0037064039
-
Regulation of MDR-1 (P-glycoprotein) by cyclooxygenase-2
-
12138126
-
V.A.Patel, M.J.Dunn, A.Sorokin. Regulation of MDR-1 (P-glycoprotein) by cyclooxygenase-2. J Biol Chem 2002; 277:38915-20; PMID:12138126; http://dx.doi.org/10.1074/jbc.M206855200
-
(2002)
J Biol Chem
, vol.277
, pp. 38915-38920
-
-
Patel, V.A.1
Dunn, M.J.2
Sorokin, A.3
-
30
-
-
84855720904
-
Inflammation and cancer: a comparative view
-
22151229
-
W.B.Morrison. Inflammation and cancer: a comparative view. J Vet Intern Med 2012; 26:18-31; PMID:22151229; http://dx.doi.org/10.1111/j.1939-1676.2011.00836.x
-
(2012)
J Vet Intern Med
, vol.26
, pp. 18-31
-
-
Morrison, W.B.1
-
31
-
-
0034886143
-
Toll-like receptors: critical proteins linking innate and acquired immunity
-
11477402
-
S.Akira, K.Takeda, T.Kaisho. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001; 2:675-80; PMID:11477402; http://dx.doi.org/10.1038/90609
-
(2001)
Nat Immunol
, vol.2
, pp. 675-680
-
-
Akira, S.1
Takeda, K.2
Kaisho, T.3
-
32
-
-
77956825557
-
Contribution of gut bacteria to liver pathobiology
-
20706692
-
G.Son, M.Kremer, I.N.Hines. Contribution of gut bacteria to liver pathobiology. Gastroenterol Res Practice 2010; 2010; PMID:20706692; http://dx.doi.org/10.1155/2010/453563
-
(2010)
Gastroenterol Res Practice
, pp. 2010
-
-
Son, G.1
Kremer, M.2
Hines, I.N.3
-
33
-
-
34250858888
-
Altered p-STAT3 (tyr705) expression is associated with histological grading and intratumour microvessel density in hepatocellular carcinoma
-
16901975
-
S.F.Yang, S.N.Wang, C.F.Wu, Y.T.Yeh, C.Y.Chai, S.C.Chunag, M.C.Sheen, K.T.Lee. Altered p-STAT3 (tyr705) expression is associated with histological grading and intratumour microvessel density in hepatocellular carcinoma. J Clin Pathol 2007; 60:642-8; PMID:16901975; http://dx.doi.org/10.1136/jcp.2006.036970
-
(2007)
J Clin Pathol
, vol.60
, pp. 642-648
-
-
Yang, S.F.1
Wang, S.N.2
Wu, C.F.3
Yeh, Y.T.4
Chai, C.Y.5
Chunag, S.C.6
Sheen, M.C.7
Lee, K.T.8
-
34
-
-
0034254225
-
Role of Stat3 in lipopolysaccharide-induced IL-10 gene expression
-
10903771
-
E.M.Benkhart, M.Siedlar, A.Wedel, T.Werner, H.W.Ziegler-Heitbrock. Role of Stat3 in lipopolysaccharide-induced IL-10 gene expression. J Immunol 2000; 165:1612-7; PMID:10903771; http://dx.doi.org/10.4049/jimmunol.165.3.1612
-
(2000)
J Immunol
, vol.165
, pp. 1612-1617
-
-
Benkhart, E.M.1
Siedlar, M.2
Wedel, A.3
Werner, T.4
Ziegler-Heitbrock, H.W.5
-
35
-
-
79251578016
-
IL-6 trans-signaling modulates TLR4-dependent inflammatory responses via STAT3
-
21148800
-
C.J.Greenhill, S.Rose-John, R.Lissilaa, W.Ferlin, M.Ernst, P.J.Hertzog, A.Mansell, B.J.Jenkins. IL-6 trans-signaling modulates TLR4-dependent inflammatory responses via STAT3. J Immunol 2011; 186:1199-208; PMID:21148800; http://dx.doi.org/10.4049/jimmunol.1002971
-
(2011)
J Immunol
, vol.186
, pp. 1199-1208
-
-
Greenhill, C.J.1
Rose-John, S.2
Lissilaa, R.3
Ferlin, W.4
Ernst, M.5
Hertzog, P.J.6
Mansell, A.7
Jenkins, B.J.8
-
36
-
-
23744481633
-
Evaluation of potential Stat3-regulated genes in human breast cancer
-
16081048
-
F.C.Hsieh, G.Cheng, J.Lin. Evaluation of potential Stat3-regulated genes in human breast cancer. Biochem Biophys Research Commun 2005; 335:292-9; PMID:16081048; http://dx.doi.org/10.1016/j.bbrc.2005.07.075
-
(2005)
Biochem Biophys Research Commun
, vol.335
, pp. 292-299
-
-
Hsieh, F.C.1
Cheng, G.2
Lin, J.3
-
37
-
-
46949093659
-
p38/NF-kB-dependent expression of COX-2 during differentiation and inflammatory response of chondrocytes
-
18286508
-
V.Ulivi, P.Giannoni, C.Gentili, R.Cancedda, F.Descalzi. p38/NF-kB-dependent expression of COX-2 during differentiation and inflammatory response of chondrocytes. J Cell Biochem 2008; 104:1393-406; PMID:18286508; http://dx.doi.org/10.1002/jcb.21717
-
(2008)
J Cell Biochem
, vol.104
, pp. 1393-1406
-
-
Ulivi, V.1
Giannoni, P.2
Gentili, C.3
Cancedda, R.4
Descalzi, F.5
-
38
-
-
62349138124
-
The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment
-
A.Greenhough, H.J.Smartt, A.E.Moore, H.R.Roberts, A.C.Williams, C.Paraskeva, A.Kaidi. The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis 2009; 30:377-86; PMID:19136477; http://dx.doi.org/10.1093/carcin/bgp014
-
(2009)
Carcinogenesis
, vol.30
, pp. 377-386
-
-
Greenhough, A.1
Smartt, H.J.2
Moore, A.E.3
Roberts, H.R.4
Williams, A.C.5
Paraskeva, C.6
Kaidi, A.7
-
39
-
-
84959357925
-
Tang Nanhong H-BSIoFP, Union Hospital, Fujian Medical University. Correlation between hepatocellular carcinoma and the expressions of prostaglandin E2, mPGES-1 and HBx (in Chinese)
-
W.Yan, W.Xiaoqian, L.Xiujin, Tang Nanhong H-BSIoFP, Union Hospital, Fujian Medical University. Correlation between hepatocellular carcinoma and the expressions of prostaglandin E2, mPGES-1 and HBx (in Chinese). J Clin Hepatol 2011; 27:174-7
-
(2011)
J Clin Hepatol
, vol.27
, pp. 174-177
-
-
Yan, W.1
Xiaoqian, W.2
Xiujin, L.3
-
41
-
-
0036208533
-
The MDR phenotype is associated with the expression of COX-2 and iNOS in a human hepatocellular carcinoma cell line
-
11915030
-
O.Fantappie, E.Masini, I.Sardi, L.Raimondi, D.Bani, M.Solazzo, A.Vannacci, R.Mazzanti. The MDR phenotype is associated with the expression of COX-2 and iNOS in a human hepatocellular carcinoma cell line. Hepatology 2002; 35:843-52; PMID:11915030; http://dx.doi.org/10.1053/jhep.2002.32469
-
(2002)
Hepatology
, vol.35
, pp. 843-852
-
-
Fantappie, O.1
Masini, E.2
Sardi, I.3
Raimondi, L.4
Bani, D.5
Solazzo, M.6
Vannacci, A.7
Mazzanti, R.8
-
42
-
-
79955775908
-
COX-2 contributes to P-glycoprotein-mediated multidrug resistance via phosphorylation of c-Jun at Ser63/73 in colorectal cancer
-
21296766
-
H.Sui, S.Zhou, Y.Wang, X.Liu, L.Zhou, P.Yin, Z.Fan, Q.Li. COX-2 contributes to P-glycoprotein-mediated multidrug resistance via phosphorylation of c-Jun at Ser63/73 in colorectal cancer. Carcinogenesis 2011; 32:667-75; PMID:21296766; http://dx.doi.org/10.1093/carcin/bgr016
-
(2011)
Carcinogenesis
, vol.32
, pp. 667-675
-
-
Sui, H.1
Zhou, S.2
Wang, Y.3
Liu, X.4
Zhou, L.5
Yin, P.6
Fan, Z.7
Li, Q.8
-
43
-
-
34748831139
-
Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice
-
17683579
-
X.L.Zhang, Z.Jian, L.H.Wang, H.M.Wei, Z.G.Tian. Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice. Bmc Cancer 2007; 7:149; PMID:17683579; http://dx.doi.org/10.1186/1471-2407-7-149
-
(2007)
Bmc Cancer
, vol.7
, pp. 149
-
-
Zhang, X.L.1
Jian, Z.2
Wang, L.H.3
Wei, H.M.4
Tian, Z.G.5
-
44
-
-
2942755603
-
Characterization of interleukin-15 gene-modified human natural killer cells: implications for adoptive cellular immunotherapy
-
15020274
-
J.Zhang, R.Sun, H.M.Wei, J.H.Zhang, Z.G.Tian. Characterization of interleukin-15 gene-modified human natural killer cells: implications for adoptive cellular immunotherapy. Haematologica 2004; 89:338-47; PMID:15020274
-
(2004)
Haematologica
, vol.89
, pp. 338-347
-
-
Zhang, J.1
Sun, R.2
Wei, H.M.3
Zhang, J.H.4
Tian, Z.G.5
-
45
-
-
34447277894
-
Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection
-
17577038
-
Q.Gao, S.J.Qiu, J.Fan, J.Zhou, X.Y.Wang, Y.S.Xiao, Y.Xu, Y.W.Li, Z.Y.Tang. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol 2007; 25:2586-93; PMID:17577038; http://dx.doi.org/10.1200/JCO.2006.09.4565
-
(2007)
J Clin Oncol
, vol.25
, pp. 2586-2593
-
-
Gao, Q.1
Qiu, S.J.2
Fan, J.3
Zhou, J.4
Wang, X.Y.5
Xiao, Y.S.6
Xu, Y.7
Li, Y.W.8
Tang, Z.Y.9
|